- Home»
- The Billing Beat Newsletter»
- Effective March 3, 2021 – BCBS Policy Genotype-Guided Warfarin Dosing Updated
Effective March 3, 2021 – BCBS Policy Genotype-Guided Warfarin Dosing Updated
March 10, 2021As of March 3, 20201
Description section updated. Title changed from Genetic Testing for Warfarin Dose to Genetic Testing for Warfarin Dose
In Policy section:
• Added “P450 4F2 (CYP42)”
• Removed “international normalized ratio”
• Removed Policy Guidelines Rationale section
In Coding section:
• Added code: 0030U
The source page for this article has moved or has expired.
Please visit the Billing Beat News or Beyond Billing Blog for relevant information or search our site for specific information related to this article.
Original source URL:
https://www.bcbsks.com/CustomerService/Providers/MedicalPolicies/policies/policies/Genotype-GuidedWarfarinDosing_2021-02-10.pdf